Table 4.
Factors associated with RSV testing (n = 10,410)
| OR (95% CI) | aOR (95% CI) | |
|---|---|---|
| Age | 0.99 (0.99, 0.99) | 0.99 (0.99, 0.99) |
| Race | ||
| White | 0.98 (0.89, 1.07) | 0.95 (0.86, 1.04) |
| All non‐white | Reference | Reference |
| Sex | ||
| Female | 1.04 (0.95, 1.13) | 1.01 (0.92, 1.10) |
| Male | Reference | Reference |
| RSV prophylaxis eligibility | ||
| Yes | 1.59 (1.26, 2.01) | 1.65 (1.28, 2.13) |
| No | Reference | Reference |
| Bronchiolitis severity | ||
| EDV | 1.25 (1.01, 1.54) | 1.31 (1.05, 1.63) |
| Hospitalization | 14.16 (11.61, 17.27) | 12.96 (10.54, 15.94) |
| OPV | Reference | Reference |
| Test month | ||
| January | 9.46 (3.83, 23.39) | 9.08 (3.60, 22.93) |
| February | 6.92 (2.79, 17.12) | 6.43 (2.55, 16.26) |
| March | 5.54 (2.23, 13.76) | 5.21 (2.05, 13.20) |
| April | 3.95 (1.57, 9.96) | 3.80 (1.47, 9.79) |
| May | 2.43 (0.92, 6.39) | 2.46 (0.91, 6.62) |
| June | 0.71 (0.21, 2.39) | 0.58 (0.17, 2.04) |
| July | Reference | Reference |
| August | 0.41 (.077, 2.17) | 0.41 (0.07, 2.24) |
| September | 2.34 (0.83, 6.58) | 2.28 (0.79, 6.58) |
| October | 5.27 (2.05, 13.58) | 4.92 (1.86, 13.00) |
| November | 9.10 (3.63, 22.85) | 8.88 (3.46, 22.79) |
| December | 10.73 (4.32, 26.63) | 10.79 (4.26, 27.35) |
aOR = adjusted (multivariable) odds ratio, OR = Odds ratio, and CI = Confidence interval